Abstract Details

Title Treatment with Purified Human Anti-Abeta Antibodies Alters beta-Amyloid Levels in the Serum, CSF and Brain of APP[sup]V717F[/sup] Transgenic Mice

Topic Aging and Dementia

Presentation(s) (-)

Poster/Presentation
Number 002

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
	No disclosure on file
Jeffrey M. Kornitzer, MD, FAAN (New Jersey Pediatric Neuroscience Institute (NJPNI))	Dr. Kornitzer has nothing to disclose.
	No disclosure on file
	No disclosure on file
Nizar Souayah, MD, FAAN (NJMS)	Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��